Sun Wei, Sugiyama Kenji, Asakawa Tetsuya, Ito-Yamashita Tae, Namba Hiroki
Department of Neurosurgery, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
Neurol Med Chir (Tokyo). 2013;53(1):7-11. doi: 10.2176/nmc.53.7.
Our previous studies showed differences in striatal D(2) receptor functional activity between two different rat parkinsonian models, with lesions induced by 6-hydroxydopamine injection in the striatum and in the medial forebrain bundle (MFB) at both early (4 weeks) and later (6 months) stages after lesioning. The present study compared behavioral changes, including rotational movements induced by methamphetamine and bromocriptine, and the stepping test, in both models at both stages. No differences in behavioral performance were observed between the early and later stages in both striatal and MFB lesion models, whereas simultaneous D(2) receptor study showed dynamic change in D(2) receptors in MFB lesion rats. Behavioral characteristics might be controlled by comprehensive effects of the whole dopaminergic system, instead of variation in a few parameters of the dopaminergic system. More behavioral tests of different mechanisms with simultaneous molecular studies are needed for evaluation of parkinsonian animal models and the efficacy of treatments.
我们之前的研究表明,在两种不同的大鼠帕金森病模型中,纹状体D(2)受体功能活性存在差异,这两种模型分别是在纹状体和内侧前脑束(MFB)注射6-羟基多巴胺诱导损伤,且在损伤后的早期(4周)和晚期(6个月)均进行了观察。本研究比较了两种模型在两个阶段的行为变化,包括甲基苯丙胺和溴隐亭诱导的旋转运动以及步测。在纹状体和MFB损伤模型的早期和晚期之间,未观察到行为表现的差异,而同时进行的D(2)受体研究显示,MFB损伤大鼠的D(2)受体存在动态变化。行为特征可能受整个多巴胺能系统的综合作用控制,而非多巴胺能系统少数参数的变化。为了评估帕金森病动物模型和治疗效果,需要进行更多具有不同机制的行为测试并同时进行分子研究。